Lung Ultrasound in Pleuritic Chest Pain (UPP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02107001|
Recruitment Status : Completed
First Posted : April 8, 2014
Last Update Posted : December 2, 2015
|Condition or disease||Intervention/treatment|
|Community Acquired Pneumonia Pleuritis Pulmonary Embolism Lung Cancer||Procedure: Lung ultrasound|
|Study Type :||Observational|
|Estimated Enrollment :||400 participants|
|Official Title:||Lung Ultrasound in Pleuritic Chest Pain: a Multicenter, Prospective, Diagnostic Accuracy Study.|
|Study Start Date :||March 2014|
|Actual Primary Completion Date :||November 2015|
|Actual Study Completion Date :||November 2015|
Patients with pleuritic chest pain
Study investigators will perform lung ultrasound in each patient with pleuritic chest pain at inclusion
Procedure: Lung ultrasound
Lung ultrasonography performed and interpreted by a physician (Pulmonologist or Emergency Physician) possessing specific knowledge in the procedure and a training of at least 100 thoracic ultrasonographies in accordance to a prespecified protocol.
Other Name: Lung sonography
- Sensitivity and specificity of lung ultrasound in pneumonia, chest wall pain, lung cancer, pulmonary embolism or other causes in patients presenting with pleuritic chest pain. [ Time Frame: 30 days ]Sensitivity and specificity, positive and negative predictive values of lung ultrasound in pneumonia, chest wall pain, lung cancer, pulmonary embolism or other causes in patients presenting with pleuritic chest pain.
- Accuracy of ultrasound in distinguishing lung consolidation in pneumonia, atelectasis, pulmonary infarction or tumors [ Time Frame: 30 days ]Accuracy of ultrasound in differentiating consolidation in distinguishing lung consolidation in pneumonia, atelectasis, pulmonary infarction, tumors or other diseases with respect to the final diagnosis stated by a scientific committee.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02107001
|Emergency Department, Azienda Ospedaliera Universitaria Careggi, Firenze.|
|USC Pneumologia, Azienda Ospedaliera della Provincia di Lodi|
|- U.O.C Broncopneumologia, IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano.|
|Emergency Department, San Paolo Hospital|
|Respiratory Unit, San Paolo Hospital, Dipartimento Scienze della Salute, Università degli Studi di Milano.|
|S.O.C. Pneumologia, Ospedale S. Luca, Rovigo.|
|- Dipartimento di Medicina d'Urgenza, Ospedale Universitario, S. Luigi Gonzaga, Orbassano (TO).|
|Principal Investigator:||Giuseppe Francesco Sferrazza Papa, M.D.||Respiratory Unit, San Paolo Hospital, Dipartimento Scienze della Salute, Università degli Studi di Milano, Milan, Italy.|
|Study Chair:||Stefano Centanni, M.D, Ph.D.||Respiratory Unit, San Paolo Hospital, Dipartimento Scienze della Salute, Università degli Studi di Milano, Milan, Italy.|
|Study Director:||Giovanni Volpicelli, M.D.||Emergency Medicine staff Physician San Luigi Gonzaga University Hospital Torino, Italy.|